Clinical Trial Update: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates show Erlotinib tested in patients with advanced Non-small Cell Lung Cancer, Ovarian Epithelial Cancer, and Head and Neck Squamous Cell Ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Epithelial Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1, Phase 2 | Status: COMPLETED